Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Highly expanded clones representing different lymphocyte lineages are present in individual patients with granulomatous uveitis
Author Affiliations & Notes
  • Michael Paley
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Lynn Marisa Hassman
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Ekaterina Esaulova
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Grace L Paley
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Jennifer Laurent
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Luke Springer
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Lacey Feigl
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Max Artyomov
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Wayne Yokoyama
    Washington University in St. Louis, Saint Louis, Missouri, United States
  • Footnotes
    Commercial Relationships   Michael Paley, None; Lynn Hassman, None; Ekaterina Esaulova, None; Grace Paley, None; Jennifer Laurent, None; Luke Springer, None; Lacey Feigl, None; Max Artyomov, None; Wayne Yokoyama, None
  • Footnotes
    Support  Rheumatology Research Foundation, Barnes-Jewish Hospital Foundation
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3661. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Paley, Lynn Marisa Hassman, Ekaterina Esaulova, Grace L Paley, Jennifer Laurent, Luke Springer, Lacey Feigl, Max Artyomov, Wayne Yokoyama; Highly expanded clones representing different lymphocyte lineages are present in individual patients with granulomatous uveitis. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3661.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The pathogenic lymphocytes in human uveitis has been inferred based on abundance within an ocular or pathological sample. Here, we evaluated lymphocyte clonal expansion to provide a stronger link between putative antigen-specific responses and pathophysiology in uveitis.

Methods : We performed single cell RNA-sequencing (scRNAseq) to obtain an unbiased gene expression survey of aqueous and blood immune cells in 4 subjects with chronic granulomatous uveitis. This analysis allowed quantification, cell type identification, and transcriptional profiling of individual lymphocytes within the inflamed eye as compared to cells in circulation, along with T cell receptor and B cell receptor sequencing to determine clonotype distribution.

Results : The majority of aqueous immune cells were T cells with a ratio of CD4:CD8 T cells of approximately 2:1 for all four patients. Despite this consistent proportion of ocular T cells across individuals, each subject contained highly expanded lymphocyte clonotypes from different lineages, e.g. CD4 T cells, CD8 T cells, or B cells, where 1-3 clonotypes accounted for ~25-33% of all sequenced cells in that lineage. While CD8 T cells demonstrated similar transcriptional programming in the eye across all patients, ocular CD4 T cell responses were individualized, further defining each subjects’ inflammatory process.

Conclusions : While previous reports have suggested the most abundant cell type is central to disease pathogenesis, the current data suggest that lower frequency lymphocyte populations, such as CD8 T cells or B cells, display antigen-specific responses that drive granulomatous uveitis. Furthermore, extensive clonal expansion was seen in a different lymphocyte lineage for each individual, suggesting a distinct antigen-specific response in each patient. Further investigation of these expanded lymphocyte clones and the corresponding CD4 T cell response may identify personalized therapeutic targets.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×